Old National Bancorp’s Alexion Pharmaceuticals ALXN Stock Holding History

Old National Bancorp’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,542	Closed	-$202K	–	584
2019 Q2	$202K	Buy	1,542 +30	+2%	+$3.87K	0.01%	539
2019 Q1	$204K	Buy	+1,512	New	+$188K	0.01%	540
2017 Q2	–	Sell	-8,867	Closed	-$1.07M	–	645
2017 Q1	$1.07M	Sell	8,867 -3,329	-27%	-$429K	0.06%	231
2016 Q4	$1.49M	Sell	12,196 -1,711	-12%	-$209K	0.09%	190
2016 Q3	$1.7M	Buy	13,907 +4,663	+50%	+$600K	0.1%	165
2016 Q2	$1.08M	Buy	9,244 +1,040	+13%	+$148K	0.06%	222
2016 Q1	$1.14M	Buy	8,204 +891	+12%	+$131K	0.07%	213
2015 Q4	$1.4M	Buy	7,313 +2,059	+39%	+$360K	0.08%	182
2015 Q3	$822K	Buy	5,254 +890	+20%	+$162K	0.05%	238
2015 Q2	$789K	Buy	+4,364	New	+$753K	0.04%	259

Other funds holding ALXN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Old National Bancorp's ALXN Position: Q3 2019 in Review

Old National Bancorp sold out of Alexion Pharmaceuticals (ALXN) in Q3 2019, closing a stake of 1,542 shares — an estimated $202K sold.

Old National Bancorp first reported a position in ALXN in Q2 2015 and held it in 10 quarters. The position peaked at $1.7M in Q3 2016. 648 funds tracked by Wall St. Rank hold ALXN as of Q3 2019.

Old National Bancorp reported no remaining Alexion Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Old National Bancorp sold 1,542 Alexion Pharmaceuticals shares in Q3 2019, an estimated $202K.
Old National Bancorp first reported a position in Alexion Pharmaceuticals in Q2 2015 and held it in 10 quarters.
Old National Bancorp's Alexion Pharmaceuticals position peaked at $1.7M in Q3 2016.
648 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2019.

Based on Old National Bancorp's 13F filing for Q3 2019, filed 22 Oct 2019.